Sign in
4

Changes in Ownership

Dogwood Therapeutics, Inc. Filed Acc 0001415889-22-007087

Options or other derivatives

  • Director acquired 5,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Thomas John C Director 2022-06-23 Grant or award · Stock Option (right to buy) +5,250 5,250 D: show line 1 in the form
Loading xslF345X03/form4-06302022_110637.xml…